| 206.49 6.01 (3%) | 10-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 249.03 |
1-year : | 290.87 |
| Resists | First : | 213.21 |
Second : | 249.03 |
| Pivot price | 207.23 |
|||
| Supports | First : | 203.12 |
Second : | 196.88 |
| MAs | MA(5) : | 204.27 |
MA(20) : | 206.45 |
| MA(100) : | 192.89 |
MA(250) : | 178.1 |
|
| MACD | MACD : | -0.3 |
Signal : | 0.4  |
| %K %D | K(14,3) : | 34.3 |
D(3) : | 29.1 |
| RSI | RSI(14): 50.7 |
|||
| 52-week | High : | 217.1 | Low : | 148.79 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IBB ] has closed above bottom band by 44.0%. Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 207.05 - 208.05 | 208.05 - 208.92 |
| Low: | 198.15 - 199.3 | 199.3 - 200.29 |
| Close: | 204.74 - 206.55 | 206.55 - 208.12 |
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Tue, 06 Oct 2026
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher - 24/7 Wall St.
Mon, 05 Oct 2026
Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB - The Motley Fool
Sun, 04 Oct 2026
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist - TradingView
Thu, 01 Oct 2026
iShares Biotechnology ETF (IBB) Options Chain - Yahoo! Finance Canada
Sun, 27 Sep 2026
IBB Top Holdings List & Exposure (iShares Biotechnology ETF) - MarketBeat
Fri, 25 Sep 2026
Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK - The Motley Fool
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|